Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

April 25, 2023
Purdue Pharma Gets OK To Sell Over-The-Counter Business

A New York bankruptcy judge gave pharmaceutical maker Purdue Pharma permission Tuesday to put its over-the-counter business on the auction block next month with a $397 million stalking horse bid.
April 06, 2023
Purdue Seeking OK To Put Over-The-Counter Biz Up For Sale

Purdue Pharma is seeking permission from a New York bankruptcy judge to put its over-the-counter business up for auction with a $397 million stalking horse bid from a subsidiary of Arcadia Consumer Healthcare.
January 24, 2023
Purdue Warns Tribe's NY Lawsuit Could 'Blow Up' Ch. 11 Plan

Purdue Pharma LP urged a New York bankruptcy court on Tuesday to reject a demand from an Indigenous tribe in Canada to lift a freeze on litigation against the bankrupt drugmaker and its Sackler family owners so the tribe can pursue its claims against the Sacklers in state court.
November 10, 2022
McKinsey Wants NY Opioid Suits Moved To Bankruptcy Court

McKinsey & Co. is seeking to move a pair of New York state court suits over its alleged role in Purdue Pharma's opioid marketing efforts to bankruptcy court, saying there is a "strong interconnection" between the cases and Purdue's Chapter 11 case.
June 21, 2022
Revlon Case Opens, And LATAM Lands Its Ch. 11 Plan

Cosmetics behemoth Revlon Inc. filed for bankruptcy in the midst of a liquidity crisis, a South American airline brings its Chapter 11 plan in for a landing, and the next phase in Puerto Rico's restructuring nears a creditor vote. This is the week in bankruptcy.
June 15, 2022
Judge Trims CEO's Bonus Pay At His Last Purdue Hearing

A New York bankruptcy judge on Wednesday wound down more than two and a half years presiding over Purdue Pharma LP's contentious Chapter 11 with a ruling approving a trimmed-down incentive payment package for the opioid maker's CEO.
May 24, 2022
Week In Bankruptcy: Dioceses Settle; Wind-Downs Reined In?

Three Roman Catholic dioceses are pushing for approvals of settlements for hundreds of sexual abuse claims in bankruptcy courts, a Delaware state court judge denied a litigation stay in a nonbankruptcy wind-down case, potentially signaling a crackdown, and Purdue Pharma executives got their bonuses approved. This is the week in bankruptcy.
May 18, 2022
Purdue Ch. 11 Bonus Plan Gets Court OK, CEO's Delayed

Timing adjustments and tweaks defused the limited objections to a $33.8 million bonus package for key employees of bankrupt Purdue Pharma LP, with the plan winning approval Wednesday from a federal bankruptcy judge in the Southern District of New York.
May 17, 2022
The Week In Bankruptcy: Purdue Bonus, PR Pension Appeal

Two dozen states objected to proposed bonus payments for the CEO of bankrupt drugmaker Purdue Pharma, the First Circuit declined to rehear an appeal over changes made to Puerto Rican teacher pensions as part of the island's restructuring, and Affordable Care Act penalties are taxes in bankruptcy court. This is the week in bankruptcy.
May 13, 2022
States Say Purdue CEO Should Answer For Opioid Crisis Role

A group of state attorneys general have once again objected to proposed bonus payments for Purdue Pharma LP's CEO, telling a New York bankruptcy judge that he was a part of the corporate culture that led to the national opioid crisis.

← Previous
…
4
5
6
7
8
9
10
11
12
…
Next →